Campylobacter jejuni lipopolysaccharides from Guillain-Barre syndrome patients induce IgG anti-GM1 antibodies in rabbits

Journal of Neuroimmunology

Volumn 104, Issue 2, 2000, Pages 133-138

  Ang, C W ^a   Endtz, H Ph ^a   Jacobs, B C ^a   Laman, J D ^a   De Klerk, M A ^a   Van Der Meche F G A ^a   Van Doorn, P A ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Animal model; Anti GM1 antibodies; Campylobacter jejuni; Lipopolysaccharide

Indexed keywords

AUTOANTIBODY; GANGLIOSIDE GM1; IMMUNOGLOBULIN M ANTIBODY; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; GUILLAIN BARRE SYNDROME; MOLECULAR MIMICRY; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES; ANTIBODY FORMATION; CAMPYLOBACTER JEJUNI; DISEASE MODELS, ANIMAL; EPITOPES; G(M1) GANGLIOSIDE; G(M2) GANGLIOSIDE; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDES; RABBITS; TIME FACTORS;

EID: 0034193005     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00279-9     Document Type: Article

References (21)

1. Alfonso M., Vazquez A.M., Carr A., et al. T cell-independent B cell response to self-monosialogangliosides: primary response monoclonal antibodies. Hybridoma. 14:1995;209-216.
2. Ang C.W., Van Doorn P.A., Endtz H.P., et al. A single case of Guillain-Barré syndrome in a family with Campylobacter jejuni enteritis [abstract]. J. Neurol. 245:1998;417.
3. Aspinall G.O., Fujimoto S., McDonald A.G., Pang H., Kurjanczyk L.A., Penner J.L. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect. Immun. 62:1994;2122-2125.
4. Freimer M.L., McIntosh K., Adams R.A., Alving C.R., Drachman D.B. Gangliosides elicit a T-cell independent antibody response. J. Autoimmun. 6:1993;281-289.
5. Gregson N.A., Rees J.H., Hughes R.A.C. Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barré syndrome. J. Neuroimmunol. 73:1997;28-36.
6. Hirabayashi Y., Suzuki T., Suzuki Y., et al. A new method for purification of anti-glycosphingolipid antibody. Avian anti-hematoside (NeuGc) antibody. J. Biochem. (Tokyo). 94:1983;327-330.
7. Jacobs B.C., Endtz H.P., Van der Meché F.G.A., Hazenberg M.P., De Klerk M.A., Van Doorn P.A. Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome. J. Neuroimmunol. 79:1997;62-68.
8. Jacobs B.C., Hazenberg M.P., Van Doorn P.A., Endtz H.P., Van der Meché F.G.A. Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome. J. Infect. Dis. 175:1997;729-733.
9. Jacobs B.C., Van Doorn P.A., Schmitz P.I.M., et al. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome. Ann. Neurol. 40:1996;181-187.
10. Kusunoki S., Chiba A., Tai T., Kanazawa I. Localization of GM1 and GD1b antigens in the human peripheral nervous system. Muscle Nerve. 16:1993;752-756.
11. Kusunoki S., Shimizu J., Chiba A., Ugawa Y., Hitoshi S., Kanazawa I. Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann. Neurol. 39:1996;424-431.
12. O'Hanlon G.M., Paterson G.J., Veitch J., Wilson G., Willison H.J. Mapping immunoreactive epitopes in the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodies. Acta Neuropathol. (Berl). 95:1998;605-616.
13. Plomp J.J., Molenaar P.C., O' Hanlon G.M., et al. Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor endplates. Ann. Neurol. 45:1999;189-199.
14. Ritter G., Fortunato S.R., Cohen L., et al. Induction of antibodies reactive with GM2 ganglioside after immunization with lipopolysaccharides from Camplyobacter jejuni. Int. J. Cancer. 66:1996;184-190.
15. Saida T., Saida K., Dorfman S.H., et al. Experimental allergic neuritis induced by sensitization with galactocerebroside. Science. 204:1979;1103-1106.
16. Sheikh K.A., Nachamkin I., Ho T.W., et al. Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility. Neurology. 51:1998;371-378.
17. Takigawa T., Yasuda H., Kikkawa R., Shigeta Y., Saida T., Kitasato H. Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers. Ann. Neurol. 37:1995;436-442.
18. Thomas F.P., Trojaborg W., Nagy C., et al. Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol. (Berl). 82:1991;378-383.
19. Wirguin I., Briani C., Suturkova-Milosevic L., et al. Induction of anti-GM1 ganglioside antibodies by Campylobacter jejuni lipopolysaccharides. J. Neuroimmunol. 78:1997;138-142.
20. Yuki N., Taki T., Inagaki F., et al. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 178:1993;1771-1775.
21. Yuki N., Taki T., Takahashi M., et al. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann. Neurol. 36:1994;791-793.